Activin A expression is increased in cystic fibrosis (CF) patients, and activin inhibition reduces disease progression in a mouse model of CF (Hardy et al., 2015). Serum activin A and B concentrations are elevated in critically ill patients suffering acute respiratory failure (de Kretser et al., 2013). Here, INHBE is linked to acute respiratory failure.